Spots Global Cancer Trial Database for genital warts
Every month we try and update this database with for genital warts cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine | NCT00501137 | Cervical Cancer Genital Warts | HPV (Human Papi... | 9 Years - 26 Years | University of British Columbia | |
| Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021) | NCT02653118 | Cervical Cancer Vulvar Cancer Vaginal Cancer Genital Warts Human Papilloma... | V503 GARDASIL | 16 Years - 26 Years | Merck Sharp & Dohme LLC | |
| A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006) | NCT01047345 | Cervical Cancer... Vulvar Cancers Vaginal Cancers Genital Warts | V503 Placebo to V503 | 12 Years - 26 Years | Merck Sharp & Dohme LLC | |
| A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts | NCT01468636 | Genital Warts HPV | Oral Zinc Placebo | 19 Years - | University of British Columbia | |
| Effectiveness Study of Gardasil on Condyloma | NCT01553994 | Condyloma Genital Warts | 13 Years - 25 Years | Karolinska Institutet | ||
| Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Small Genital Warts | NCT03948321 | Genital Warts | Aminolevulinic ... | 18 Years - | Shanghai Dermatology Hospital | |
| A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts | NCT01468636 | Genital Warts HPV | Oral Zinc Placebo | 19 Years - | University of British Columbia | |
| Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015) | NCT00092534 | Cervical Cancer Genital Warts | Gardasil, human... Matching Placeb... | 16 Years - 23 Years | Merck Sharp & Dohme LLC | |
| SR-T100 Gel Efficacy & Safety Study for Vulva Pre-cancerous Lesions & Cutaneous Condyloma | NCT01676792 | Vulvar Intraepi... Genital Warts | SR-T100 gel wit... | 20 Years - | National Cheng-Kung University Hospital | |
| A Study to Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China | NCT05662020 | Human Papilloma... | Recombinant Non... GARDASIL® 9 | 9 Years - 26 Years | Beijing Health Guard Biotechnology, Inc | |
| Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001) | NCT00520598 | Cervical Cancer Vulvar Cancer Vaginal Cancer Genital Warts Human Papilloma... | Comparator: V50... Comparator: V50... Comparator: V50... Comparator: V50... Comparator: Qua... Comparator: Pla... | 16 Years - 26 Years | Merck Sharp & Dohme LLC | |
| Alternate Dosing Schedules Study for HPV Vaccine (ADS) | NCT02280642 | Cervical Cancer Genital Warts | Both 2nd and 3r... 2nd dose late a... 2nd dose on tim... Both doses late | 9 Years - 18 Years | Duke University | |
| HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3 | NCT02558803 | Human Papilloma... Human Papilloma... Human Papilloma... Human Papilloma... Cervical Cancer Genital Warts Oropharyngeal C... | Simple Reminder | 11 Years - 17 Years | Regenstrief Institute, Inc. | |
| Topical NVN1000 for the Treatment of External Genital and Perianal Warts | NCT02462187 | Genital Warts Perianal Warts | NVN1000 8% Gel NVN1000 16% Vehicle NVN1000 24% | 18 Years - 50 Years | Novan, Inc. | |
| Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003) | NCT01651949 | Genital Warts Anal Cancer Anal Intraepith... | 9vHPV Vaccine | 16 Years - 26 Years | Merck Sharp & Dohme LLC | |
| Intralesional HPV Vaccine for Condylomata | NCT05087849 | Human Papilloma... Warts Warts, Genital Condyloma Condylomata Acu... | nonavalent huma... | 18 Years - | University of California, San Francisco | |
| Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003) | NCT01651949 | Genital Warts Anal Cancer Anal Intraepith... | 9vHPV Vaccine | 16 Years - 26 Years | Merck Sharp & Dohme LLC | |
| Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts | NCT00674739 | Genital Warts | Imiquimod 3.75% imiquimod... placebo cream | 12 Years - | Graceway Pharmaceuticals, LLC | |
| A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine | NCT05694728 | Human Papilloma... | Recombinant Non... Recombinant Qua... | 20 Years - 45 Years | Beijing Health Guard Biotechnology, Inc | |
| A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts | NCT03981822 | Condylomata Acu... Papillomavirus ... Skin Diseases, ... Skin Diseases, ... Skin Diseases Sexually Transm... Sexually Transm... Warts | VP-102 and appl... Placebo | 18 Years - | Verrica Pharmaceuticals Inc. | |
| Efficacy and Safety Study of Polyphenon E to Treat External Genital Warts | NCT00449982 | Condylomata Acu... | Polyphenon E Oi... | 18 Years - | MediGene | |
| The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases | NCT02188004 | Human Papilloma... Genital Warts | 18 Years - 55 Years | Xiamen University | ||
| Efficacy of Quadrivalent HPV Vaccine to Prevent Relapses of Genital Warts After Initial Therapeutic Response | NCT03296397 | Genital Warts | Vaccination wit... Injection of No... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts | NCT02750202 | Genital Warts | Quadrivalent HP... Hepatitis B vac... | 16 Years - | University of Pretoria | |
| Human Papillomavirus (HPV) Genotypes in Genital Warts in Colombian Population | NCT00847340 | Genital Warts HPV Infections | Biopsy Excision... | 18 Years - 45 Years | La Fundacion para la Investigacion y el Desarrollo | |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients | NCT02724254 | Condyloma | AP611074 5% gel AP611074 matchi... | 18 Years - 55 Years | Vaxart | |
| Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts | NCT00674739 | Genital Warts | Imiquimod 3.75% imiquimod... placebo cream | 12 Years - | Graceway Pharmaceuticals, LLC | |
| A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine | NCT03900572 | HPV Infections | HPV Vaccine Placebo | 9 Years - 45 Years | Shanghai Zerun Biotechnology Co.,Ltd | |
| Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts | NCT00735462 | Genital Warts | 2.5% imiquimod ... 3.75% imiquimod... Placebo cream | 12 Years - | Graceway Pharmaceuticals, LLC | |
| Human Papillomavirus (HPV) Genotypes in Genital Warts in Colombian Population | NCT00847340 | Genital Warts HPV Infections | Biopsy Excision... | 18 Years - 45 Years | La Fundacion para la Investigacion y el Desarrollo | |
| A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine | NCT05694728 | Human Papilloma... | Recombinant Non... Recombinant Qua... | 20 Years - 45 Years | Beijing Health Guard Biotechnology, Inc | |
| Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts | NCT00189293 | Genital Warts | Imiquimod vehicle cream | 18 Years - | Viatris Inc. | |
| Epidemiology, Costs and Psychosocial Consequences of Genital Warts in Valparaiso, Chile | NCT01483794 | Condylomata Acu... | 18 Years - 70 Years | Universidad de Valparaiso | ||
| Intralesional HPV Vaccine for Condylomata | NCT05087849 | Human Papilloma... Warts Warts, Genital Condyloma Condylomata Acu... | nonavalent huma... | 18 Years - | University of California, San Francisco | |
| Phase 3 Study of Imiquimod Creams in the Treatment of External Genital Warts | NCT00735462 | Genital Warts | 2.5% imiquimod ... 3.75% imiquimod... Placebo cream | 12 Years - | Graceway Pharmaceuticals, LLC | |
| Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean Population | NCT01598779 | Condylomata Acu... | 15 Years - 45 Years | University of Buenos Aires | ||
| Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9 | NCT05580341 | Cervical Cancer Genital Wart CIN VIN Papillomavirus ... | Zerun HPV-9 GARDASIL ®9 | 16 Years - 26 Years | Shanghai Zerun Biotechnology Co.,Ltd | |
| Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Small Genital Warts | NCT03948321 | Genital Warts | Aminolevulinic ... | 18 Years - | Shanghai Dermatology Hospital | |
| The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases | NCT02188004 | Human Papilloma... Genital Warts | 18 Years - 55 Years | Xiamen University | ||
| Efficacy and Safety Profiles of SR-T100 Gel on External Genital Warts/Condyloma Acuminate(EGWs) | NCT01796821 | Condyloma Acumi... Genital Warts Condylomata Acu... Venereal Warts | Vehicle gel SR-T100 gel wit... SR-T100 gel wit... | 20 Years - | G&E Herbal Biotechnology Co., LTD | |
| Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts | NCT00499967 | Genital Warts | GS-9191 ointmen... GS-9191 Placebo | 18 Years - 50 Years | Gilead Sciences | |
| A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts | NCT03981822 | Condylomata Acu... Papillomavirus ... Skin Diseases, ... Skin Diseases, ... Skin Diseases Sexually Transm... Sexually Transm... Warts | VP-102 and appl... Placebo | 18 Years - | Verrica Pharmaceuticals Inc. | |
| A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine | NCT05680454 | Human Papilloma... | Recombinant Non... Recombinant non... | 18 Years - 45 Years | Beijing Health Guard Biotechnology, Inc | |
| HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3 | NCT02558803 | Human Papilloma... Human Papilloma... Human Papilloma... Human Papilloma... Cervical Cancer Genital Warts Oropharyngeal C... | Simple Reminder | 11 Years - 17 Years | Regenstrief Institute, Inc. | |
| Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean Population | NCT01598779 | Condylomata Acu... | 15 Years - 45 Years | University of Buenos Aires | ||
| The Psychosocial and Economic Burden of Genital Warts | NCT01520194 | Female Genital ... | women attending... medical records | 18 Years - 45 Years | BEMFAM-Bem Estar Familiar | |
| Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004) | NCT03158220 | Cervical Cancer Vulvar Cancer Vaginal Cancer Genital Warts Human Papilloma... | V503 | 16 Years - 45 Years | Merck Sharp & Dohme LLC | |
| A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine | NCT00501137 | Cervical Cancer Genital Warts | HPV (Human Papi... | 9 Years - 26 Years | University of British Columbia | |
| Alternate Dosing Schedules Study for HPV Vaccine (ADS) | NCT02280642 | Cervical Cancer Genital Warts | Both 2nd and 3r... 2nd dose late a... 2nd dose on tim... Both doses late | 9 Years - 18 Years | Duke University | |
| The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases | NCT02188004 | Human Papilloma... Genital Warts | 18 Years - 55 Years | Xiamen University | ||
| Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001) | NCT00543543 | Cervical Cancer Vulvar Cancer Vaginal Cancer Genital Warts Human Papilloma... | Comparator: GAR... Experimental: V... | 16 Years - 26 Years | Merck Sharp & Dohme LLC | |
| Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts | NCT00189293 | Genital Warts | Imiquimod vehicle cream | 18 Years - | Viatris Inc. | |
| A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts | NCT03981822 | Condylomata Acu... Papillomavirus ... Skin Diseases, ... Skin Diseases, ... Skin Diseases Sexually Transm... Sexually Transm... Warts | VP-102 and appl... Placebo | 18 Years - | Verrica Pharmaceuticals Inc. | |
| Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001) | NCT00543543 | Cervical Cancer Vulvar Cancer Vaginal Cancer Genital Warts Human Papilloma... | Comparator: GAR... Experimental: V... | 16 Years - 26 Years | Merck Sharp & Dohme LLC | |
| SR-T100 Gel Efficacy & Safety Study for Vulva Pre-cancerous Lesions & Cutaneous Condyloma | NCT01676792 | Vulvar Intraepi... Genital Warts | SR-T100 gel wit... | 20 Years - | National Cheng-Kung University Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
